Leonel Ampie1, Winward Choy1, Jonathan B Lamano1, Kartik Kesavabhotla1, Qinwen Mao2, Andrew T Parsa1, Orin Bloch3. 1. Department of Neurological Surgery Northwestern University, Feinberg School of Medicine, Chicago, IL, USA. 2. Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA. 3. Department of Neurological Surgery Northwestern University, Feinberg School of Medicine, Chicago, IL, USA. Electronic address: orin.bloch@northwestern.edu.
Abstract
OBJECTIVE: Chordoid gliomas (CG) are rare neoplasms which frequently arise within the third ventricle. Surgery remains the mainstay treatment for CG. The present study comprehensively reviews all reported cases of CG within the literature in order to identify risk factors for surgical complications and tumor recurrence. METHODS: A comprehensive search on MEDLINE (OVID and PubMed), Scopus, Embase, and Web of Science was conducted following PRISMA guidelines to identify all reported cases of CG. RESULTS: A total of 81 patients met the study criteria which comprised of 33 males and 48 females. Median age at diagnosis was 48 years with a range from 5 to 72 years, and mean tumor size was 3.1cm. Biopsy, subtotal resection (STR), and gross total resection (GTR) were achieved in 8, 34, and 33 patients, respectively, with six cases not reporting extent of resection (EOR). Thirteen patients underwent adjuvant radiotherapy. Postoperative complications were noted in 30 cases (37%), with new onset diabetes insipidus being the most common. Postoperative morbidity was not associated with age, tumor size, or extent of resection. A trans-lamina terminalis approach demonstrated a strong trend towards decreased overall rates of postoperative morbidity compared to other approaches (p=0.051). GTR was associated with improved progression-free survival (PFS; p=0.028), while adjuvant radiotherapy, age, tumor size and proliferative index were not predictive of patient outcomes. CONCLUSION: GTR should be the primary goal for the management of CG, as it is associated with improved rates of tumor control without an increased rate of postoperative complications. Surgical approach was a stronger predictor of complication rates than extent of resection. Morbidity remains high, and future studies to further elaborate on factors predictive of postoperative complications are critical.
OBJECTIVE:Chordoid gliomas (CG) are rare neoplasms which frequently arise within the third ventricle. Surgery remains the mainstay treatment for CG. The present study comprehensively reviews all reported cases of CG within the literature in order to identify risk factors for surgical complications and tumor recurrence. METHODS: A comprehensive search on MEDLINE (OVID and PubMed), Scopus, Embase, and Web of Science was conducted following PRISMA guidelines to identify all reported cases of CG. RESULTS: A total of 81 patients met the study criteria which comprised of 33 males and 48 females. Median age at diagnosis was 48 years with a range from 5 to 72 years, and mean tumor size was 3.1cm. Biopsy, subtotal resection (STR), and gross total resection (GTR) were achieved in 8, 34, and 33 patients, respectively, with six cases not reporting extent of resection (EOR). Thirteen patients underwent adjuvant radiotherapy. Postoperative complications were noted in 30 cases (37%), with new onset diabetes insipidus being the most common. Postoperative morbidity was not associated with age, tumor size, or extent of resection. A trans-lamina terminalis approach demonstrated a strong trend towards decreased overall rates of postoperative morbidity compared to other approaches (p=0.051). GTR was associated with improved progression-free survival (PFS; p=0.028), while adjuvant radiotherapy, age, tumor size and proliferative index were not predictive of patient outcomes. CONCLUSION: GTR should be the primary goal for the management of CG, as it is associated with improved rates of tumor control without an increased rate of postoperative complications. Surgical approach was a stronger predictor of complication rates than extent of resection. Morbidity remains high, and future studies to further elaborate on factors predictive of postoperative complications are critical.
Authors: Norman E Leeds; Frederick F Lang; Teresa Ribalta; Raymond Sawaya; Gregory N Fuller Journal: Arch Pathol Lab Med Date: 2006-04 Impact factor: 5.534
Authors: Nagham Al-Zubidi; Margaret M McGlynn; Patricia Chévez-Barrios; Sushma Yalamanchili; Andrew G Lee Journal: J Neuroophthalmol Date: 2014-03 Impact factor: 3.042
Authors: D J Brat; B W Scheithauer; S M Staugaitis; S C Cortez; K Brecher; P C Burger Journal: J Neuropathol Exp Neurol Date: 1998-03 Impact factor: 3.685
Authors: Anna Maria Buccoliero; Adele Caldarella; Pasquale Gallina; Nicola Di Lorenzo; Antonio Taddei; Gian Luigi Taddei Journal: Arch Pathol Lab Med Date: 2004-11 Impact factor: 5.534
Authors: H Tonami; M Kamehiro; M Oguchi; K Higashi; I Yamamoto; T Njima; K Okamoto; T Akai; H Iizuka Journal: J Comput Assist Tomogr Date: 2000 Mar-Apr Impact factor: 1.826
Authors: Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee Journal: J Neuropathol Exp Neurol Date: 2002-03 Impact factor: 3.685
Authors: Amalie A Erwood; Jose E Velazquez-Vega; Stewart Neill; David A Solomon; Nicholas Butowski; Adam Nowlan; Erin Dunbar; Daniel J Brat Journal: J Neurooncol Date: 2017-03-18 Impact factor: 4.130
Authors: Benjamin Goode; Gourish Mondal; Michael Hyun; Diego Garrido Ruiz; Yu-Hsiu Lin; Jessica Van Ziffle; Nancy M Joseph; Courtney Onodera; Eric Talevich; James P Grenert; Iman H Hewedi; Matija Snuderl; Daniel J Brat; Bette K Kleinschmidt-DeMasters; Fausto J Rodriguez; David N Louis; William H Yong; M Beatriz Lopes; Marc K Rosenblum; Nicholas Butowski; Tarik Tihan; Andrew W Bollen; Joanna J Phillips; Arun P Wiita; Iwei Yeh; Matthew P Jacobson; Boris C Bastian; Arie Perry; David A Solomon Journal: Nat Commun Date: 2018-02-23 Impact factor: 14.919